Effects of adenosine triphosphate and reduced glutathione on biochemical, histopathological and immunofluorescence alterations associated with atezolizumab-induced cardiac tissue injury
Yesim Kaya Yasar, Esra Tuba Sezgin, Bahadir Suleyman, Renad Mammadov, Mustafa Ozkaraca, Ali Gungor, Taha Abdulkadir Coban, Halis Suleyman · 2026
Read Effects of adenosine triphosphate and reduced glutathione on biochemical, histopathological and immunofluorescence alterations associated with atezolizumab-induced cardiac tissue injury by Yesim Kaya Yasar, Esra Tuba Sezgin, Bahadir Suleyman, Renad Mammadov, Mustafa Ozkaraca, Ali Gungor, Taha Abdulkadir Coban, Halis Suleyman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13585631.txt.
Description
Yesim Kaya Yasar and co-authors test two shields against heart harm from a cancer drug in a 2026 study. The drug, atezolizumab, frees the immune system to fight tumors, yet it can hurt the heart. The team used 24 male rats in four groups: sound, drug alone, and drug plus one of two shields. The shields are ATP, the cell fuel coin, and glutathione, a guard molecule. Rats got the shields for seven days.
Drug-alone hearts showed high stress and swelling marks and low guard marks. Both shields pulled those marks back toward sound. Tissue cuts and glow tests backed the shift. The authors read ATP and glutathione as guards in this rat model. Human proof is still far off, yet the pair may seed work on safer immune cancer care.
Catalog record
| CREATOR | Yesim Kaya Yasar, Esra Tuba Sezgin, Bahadir Suleyman, Renad Mammadov, Mustafa Ozkaraca, Ali Gungor, Taha Abdulkadir Coban, Halis Suleyman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |